Therapeutic effects and potential mechanisms of astragaloside IV on pulmonary fibrosis: a systematic review and meta-analysis of preclinical studies
BackgroundPulmonary fibrosis (PF) remains a devastating disease with limited therapeutic options. Astragaloside IV (AS-IV), a natural compound from Astragalus mongholicus (AM), has shown promise as a possible treatment for fibrosis. However, a systematic evaluation of its therapeutic efficacy and un...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artikel |
| Taal: | Engels |
| Gepubliceerd in: |
Frontiers Media S.A.
2025-07-01
|
| Reeks: | Frontiers in Pharmacology |
| Onderwerpen: | |
| Online toegang: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1564290/full |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|